Triphenylamine/carbazole-modified ruthenium(<scp>ii</scp>) Schiff base compounds: synthesis, biological activity and organelle targeting
Shujiao Chen, Xicheng Liu, Jie Huang, Xingxing Ge, Qinghui Wang, Meimei Yao, Yue Shao, Tong Liu, Xiang‐Ai Yuan, Laijin Tian, Zhe Liu
Abstract
: 1.70 ± 0.56-17.75 ± 3.10 μM), which, meanwhile, can inhibit the metastasis of tumor cells effectively. These compounds follow an energy-dependent cellular uptake mechanism, mainly accumulate in lysosomes to destroy their integrity, and then eventually promote apoptosis. In addition, these compounds can induce an increase of intracellular reactive oxygen species (ROS) levels and provide an antitumor mechanism of oxidation, which is confirmed by the decrease of mitochondrial membrane potential (MMP) and the catalytic oxidation of the coenzyme nicotinamide-adenine dinucleotide (NADH). All these indicate that these ruthenium(ii) compounds are expected to be dual-functional antitumor agents: anti-metastasis and lysosomal damage.